Australasian Journal of Dermatology

Article	Citations
Poster Presentations	24
Dermoscopy, confocal microscopy and optical coherence tomography features of main inflammatory and autoimmune skin diseases: A systematic review	24
Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: A randomised, double‐blinded trial	20
Carbon footprint of dermatologic surgery	19
SARS‐CoV‐2 (COVID‐19) vaccination in dermatology patients on immunomodulatory and biologic agents: Recommendations from the Australasian Medical Dermatology Group	18
Successful secukinumab treatment of active bullous pemphigoid and chronic severe psoriasis: a case report	17
Tildrakizumab as a potential long‐term therapeutic agent for severe Hidradenitis Suppurativa: A 15 months experience of an Australian institution	16
Management of hypertrophic scars in adults: A systematic review and meta‐analysis	16
Extragenital lichen sclerosus: A comprehensive review	15
An unusual presentation of pemphigus foliaceus following COVID‐19 vaccination	15
Efficacy of topical Calendula officinalis on prevalence of radiation‐induced dermatitis: A randomised controlled trial	15
Defining the incidence of cutaneous squamous cell carcinoma in coastal NSW Australia	15
Legal and ethical considerations of artificial intelligence in skin cancer diagnosis	15
Cutaneous manifestations of viral outbreaks	15
A narrative review of the roles of topical permethrin and oral ivermectin in the management of infantile scabies	14
Paediatric and Adolescent Dermatology	13
Probiotic mixture reduces gut inflammation and microbial dysbiosis in children with atopic dermatitis	13
Topical simvastatin–cholesterol for disseminated superficial actinic porokeratosis: An open‐label, split‐body clinical trial	13
Pityriasis rosea‐like eruption revealing COVID‐19	13
Systematic review of sirolimus in dermatological conditions	12
Toxic epidermal necrolysis and Stevens‐Johnson syndrome after COVID‐19 infection and vaccination	12
Effective treatment of oral lichen planus with the JAK inhibitor baricitinib	12
Tissue eosinophil levels as a marker of disease severity in bullous pemphigoid	11
Successful treatment of chronic severe alopecia areata with abrocitinib	11
Dupilumab‐associated psoriasis and psoriasiform dermatitis in patients with atopic dermatitis	11

Two cases of vitiligo vulgaris treated with topical Janus kinase inhibitor delgocitinib	11
Is methotrexate hepatotoxicity associated with cumulative dose? A systematic review and meta‐analysis	11
Quality of life of women with untreated vulval lichen sclerosus assessed with vulval quality of life index (VQLI)	10
VEXAS syndrome: A dermatological perspective	10
Congenital melanocytic naevi: An up‐to‐date overview	10
Treatment of granuloma annulare with tofacitinib	10
Secukinumab use in the treatment of Netherton's syndrome	10
Mucormycosis with cutaneous involvement. A retrospective study of 115 cases at a tertiary care hospital in Mexico	10
Efficacy of topical versus intradermal injection of Tranexamic Acid In Egyptian melasma Patients: A randomised clinical trial	10
Clinical characteristics and predictive factors of erythema nodosum in granulomatous lobular mastitis	10
Clinical and histopathological features of onychopapilloma in an Australian setting: A case series of 50 patients	9
Factors associated with high Altmetric Attention Score in dermatology research	9
Successful management of treatment resistant nail psoriasis with tildrakizumab	9
Cutaneous mastocytosis: A dermatological perspective	9
Combination treatment with monoclonal antibodies: Secukinumab, benralizumab and dupilumab for the combined management of psoriasis and severe asthma	9
Dermoscopy and reflectance confocal microscopy of intraepidermal Merkel cell carcinoma	9
Disseminated superficial actinic porokeratosis following hydroxyurea treatment: A case report	8
A practical guide on the use of imiquimod cream to treat lentigo maligna	8
Segmental stiff skin syndrome (SSS): Clinical case and a brief review	8
Successful treatment of pityriasis rubra pilaris with tildrakizumab	8
Topical epigallocatechin‐3‐gallate in the treatment of vitiligo	8
Dupilumab successfully treated refractory bullous pemphigoid with early clinical manifestations imitating atopic dermatitis: A case letter	8
Onychopapilloma presenting as longitudinal melanonychia: A case report and literature review	8
Vulval lichen sclerosus: An Australasian management consensus	8
A machine‐learning modified CART algorithm informs Merkel cell carcinoma prognosis	8
Successful treatment of calciphylaxis in a renal transplant recipient with combination of intralesional sodium thiosulphate, intravenous sodium thiosulphate and fish skin graft	8
Novel combination biologic therapy for recalcitrant psoriasis and psoriatic arthritis in a medically complex patient	8
Thalidomide for prevention of camrelizumab‐induced reactive cutaneous capillary endothelial proliferation	8
Idiopathic Granulomatous Mastitis and Erythema nodosum – A Unifying Pathophysiology?	8
Itraconazole in the treatment of basal cell carcinoma: A case‐based review of the literature	7
Cutaneous‐group histiocytoses associated with myeloid malignancies: A systematic review of 102 cases	7
Misdiagnoses and barriers to care in hidradenitis suppurativa: A patient survey	7
A long‐term cohort study of acitretin for prevention of keratinocyte carcinoma in solid organ transplant recipients	7
Serum level of S100B in vitiligo patients: Is it a marker of disease activity?	7
A case of treatment‐resistant pityriasis rubra pilaris responsive to secukinumab	7
Pembrolizumab associated Stevens–Johnson syndrome with porokeratosis in a patient in the setting of primary hepatocellular carcinoma	7
A case of toxic epidermal necrolysis after ChAdOx1 nCov‐19 (AZD1222) vaccination	7
Effective treatment of disseminated superficial actinic porokeratosis using a novel topical cholesterol/simvastatin combination cream	7
Characteristics of 637 melanomas documented by 27 general practitioners on the Skin Cancer Audit Research Database	7
Successful treatment of vulvovaginal lichen planus with tildrakizumab: A case series of 24 patients	7
Challenges and pitfalls between lichen planus pemphigoides and bullous lichen planus	7
Combination treatment of bilateral periocular sebaceous carcinomas with microsatellite instability with neoadjuvant pembrolizumab and Mohs surgery	7
Cutaneous manifestations and dermatological sequelae of Covid‐19 infection compared to those from other viruses	7
Association study of transition of laboratory marker levels and transition of disease activity of atopic dermatitis patients treated with dupilumab	7
Epidemiological, clinical, pathological and genetic characteristics of epidermolysis bullosa in New Zealand	7
Appropriate indication and procedure for random skin biopsy in the diagnosis of intravascular large B‐cell lymphoma	6
Ultraviolet filter, fragrance and preservative allergens in New Zealand sunscreens	6
Subacute cutaneous lupus erythematosus induced by PD‐1 Inhibitor therapy: two case reports and literature review	6
	6
Reactive perforating collagenosis successfully treated with dupilumab	6

Nine cases of chronic hand and foot eczema treated with baricitinib	6
Ultrasound‐guided de‐roofing of epithelialised tunnels of hidradenitis suppurativa	6
Characteristics, treatment and outcomes of 589 melanoma patients documented by 27 general practitioners on the Skin Cancer Audit Research Database	6
Bowel‐associated dermatosis–arthritis syndrome (BADAS)	6
The impact of incomplete clinical information and initial biopsy technique on the histopathological diagnosis of cutaneous melanoma	6
Dermoscopic features of port‐wine stains: A study of 264 cases	6
Five years of dermatological disease requiring specialist care in the Kimberley region of Western Australia	6
Oral mycophenolate mofetil in the treatment of acquired dermal macular hyperpigmentation: An open‐label pilot study	6
Use of narrowband ultraviolet B (NBUVB) in paediatric psoriasis: A systematic literature review and meta‐analysis	6
Medical Dermatology	6
A casemix study of patients seen within an urban Aboriginal Health Service dermatology clinic over a five‐year period	6
Neutrophilic dermatosis: a new skin manifestation and novel pathogenic variant in a rare autoinflammatory disease	5
Clobetasol propionate 0.05% under occlusion for alopecia areata: Clinical effect and influence on intraocular pressure	5
Cutaneous adverse reactions following the Pfizer/BioNTech COVID‐19 vaccine	5
Acquired idiopathic generalized anhidrosis diagnosed following mRNA COVID‐19 vaccination—A case series	5
Informing a position statement on the use of artificial intelligence in dermatology in Australia	5
First report of cutaneous mycetoma by Paecilomyces variotii and the successful treatment with combined itraconazole and terbinafine along with resection surgeries	5
Ulcerating necrobiosis lipoidica successfully treated with ustekinumab	5
A real‐world Australian experience of upadacitinib for the treatment of severe atopic dermatitis	5
Incidence and prevalence of alopecia areata in the Australian primary care setting: A retrospective analysis of electronic health record data	5
Dermoscopic features of primary cutaneous amyloidosis in skin of colour: A retrospective analysis of 48 patients from South India	5
Bullous pemphigoid associated with anti‐programmed cell death protein 1 and anti‐programmed cell death ligand 1 therapy: A case series of 13 patients	5
Nail dermatoscopic (onychoscopic) features of nail lichen planus: A cross‐sectional study	5
PD‐1 inhibitors for cutaneous squamous cell carcinoma: A meta‐analysis	5
Is there any association between psoriasis, psoriatic arthritis and thyroid autoimmunity?	5
Australian Teledermatology experience during COVID‐19	5
Dupilumab‐associated ocular surface disease: An interdisciplinary decision framework for prescribers in the Australian setting	5
Differences in the skin microbial community between patients with active and stable vitiligo based on 16S rRNA gene sequencing	5
Moisturisers from birth in at‐risk infants of atopic dermatitis – a pragmatic randomised controlled trial	5
Onychomycosis in older adults: The age and associated factors affecting the complete cure rate	5
Talimogene laherparepvec resulting in near‐complete response in a patient with treatment‐refractory Merkel cell carcinoma	5
Multicentric reticulohistiocytosis revealing breast cancer: Report of a case with dermoscopic, radiological and therapeutic aspects	5
SUFU‐associated Gorlin syndrome: Expanding the spectrum between classic nevoid basal cell carcinoma syndrome and multiple hereditary infundibulocystic basal cell carcinoma	5
Efficacy of ustekinumab and guselkumab in treatment refractory pityriasis rubra pilaris: A case series	5
How good is the Australian baseline series at detecting allergic contact dermatitis?	5
Secukinumab treatment demonstrated high drug survival and sustained effectiveness in patients with severe chronic plaque psoriasis: 21‐month analysis in Australian routine clinical practice (SUST	5
Melanoma/Oncology	5
Clustering trends of melanoma incidence and mortality: A worldwide assessment from 1995 to 2019	5
Highlighting adalimumab as a treatment option for systemic treatment of toxic epidermal necrolysis: A case series from a tertiary specialised burns centre	5
Pigmented purpuric dermatoses versus purpuric mycosis fungoides: Clinicopathologic similarities and new insights into dermoscopic features	4
Quantifying the ultraviolet radiation emitted by nail curing devices: A descriptive study	4
Mycosis fungoides and Sézary syndrome: Australian clinical practice statement	4
Management of multiple trichoepithelioma: A review of pharmacological therapies	4
Merkel cell carcinoma in situ: A systematic review of prognosis and management	4
Relationship between PASI and FDLQI in paediatric psoriasis, and treatments used in daily clinical practice	4
	4
Histone deacetylase 1 in patients with alopecia areata and acne vulgaris: An epigenetic alteration	4
Treatment modalities and risk of adverse events associated with biologic therapy: A 10‐year observational review of the Australasian Psoriasis Registry	4
Secukinumab and infectious adverse effects: A real‐life experience of 63 psoriasis patients	4
The role of line‐field confocal optical coherence tomography (LC‐OCT) in the diagnosis of eccrine poroma: A case report	4
Risk factors for cytomegalovirus reactivation in autoimmune bullous disease patients on immunosuppressive therapy	4
Medical dermatology	4
Fractional carbon dioxide laser for treating hypertrophic scars: A systematic review of randomised trials	4
Baby wipes and nappy rash – what is the relationship? A review	4
Impact of COVID‐19 on inpatient dermatology consults in an Australian tertiary hospital	4
Long‐term dupilumab therapy in Netherton syndrome with severe atopic manifestations: Case report and review of the literature	4
Drug‐induced cutaneous pseudolymphoma: A systematic review of the literature	4
A case of pityriasis rubra pilaris treated with tofacitinib after failure with acitretin and ixekizumab	4
Development of melanoma clinical quality indicators for the Australian melanoma clinical outcomes registry (MelCOR): A modified Delphi study	4
Biologics/Psoriasis	4
Effectiveness, safety and satisfaction of 1% tirbanibulin ointment in the treatment of actinic keratoses: A prospective study in real clinical practice	4
Treatment of dissecting cellulitis of the scalp with Tildrakizumab	4
Scrutinising the role of simvastatin in a patient of Pachyonychia Congenita with KRT6A gene mutation	4
Clinical and dermatoscopic characteristics of lichen planus‐like keratosis in a West‐Asian population	4
Expression of programmed cell death ligand 1 (PD‐L1) at in situ and invasive extramammary Paget’s disease and literature review	4
Erythema multiforme following vaccination for SARS‐CoV‐2: Report of a case and review of the literature − Secondary Publication	4
Linear lichen planus after COVID‐19 vaccination	4
Acquired causes of eyebrow and eyelash loss: A review and approach to diagnosis and treatment	4
Diagnostic tools used for melanoma: A survey of Australian general practitioners and dermatologists	4
Adult female acne: Clinical characteristics and factors significantly associated with polycystic ovary syndrome	4
Blau syndrome with pulmonary nodule in a child	4
Upadacitinib effectiveness in moderate‐to‐severe atopic dermatitis: A real‐life multicentre and retrospective study	4
Effect of oral tranexamic acid on erythema index in patients with melasma	4
Benefits of skin application of piceatannol—A minireview	4
The role of artificial intelligence language models in dermatology: Opportunities, limitations and ethical considerations	4
Concurrent extramammary Paget's disease involving the genitalia and axilla: Case report and literature review	4
PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI	4
Pyoderma gangrenosum: A review of patient's demographics, disease and treatment in 118 patients	4
Increased risk of herpes zoster in patients with psoriasis: A longitudinal follow‐up study using a national sample cohort	4
Juvenile spring eruption among soldiers: A report of a large outbreak	3

Recurrent cutaneous hyalohyphomycosis secondary to Purpureocillium lilacinum in an immunocompetent individual	3
Bullous pemphigoid in a young male during treatment with adalimumab	3
Two cases of granular C3 dermatosis with intraepidermal neutrophilic and eosinophilic infiltration possibly induced by anti‐hypertensive drugs	3
Epidemiology of eczema in South‐Eastern Australia	3
Efficacy of switching from adalimumab originator to adalimumab biosimilar in moderate to severe psoriasis patients: A Real‐life experience in a tertiary referral centre	3
A case of lymphangioma circumscriptum with new reflectance confocal microscopy findings	3
Chemical peels for atrophic acne scarring: Evolution of peel types and methods	3
Efficacy and safety of tralokinumab in the treatment of head and neck pattern atopic dermatitis: A multicentre study of 12 patients	3
Immunotherapy for the treatment of penile intraepithelial neoplasia associated with human papilloma virus type 16 using topical imiquimod and human papilloma virus vaccination	3
The association between hidradenitis suppurativa and male and female infertility: A population‐based study	3
Quality of life impact and treatment response in vulval disease: Comparison of 3 common conditions using the Vulval Quality of Life Index	3
Nail dystrophy as initial presentation of systemic amyloidosis	3
Why do some patients with vulval lichen sclerosus on long‐term topical corticosteroid treatment experience ongoing poor quality of life?	3
Annular atrophic lichen planus induced by anti‐HER2 antibodies	3
Internalized stigma in chronic urticaria: A case–control study	3
Not something to sit on: A case of senile gluteal dermatosis responding to calcipotriol ointment	3
Secukinumab treatment showed improved quality of life in patients with chronic plaque psoriasis in Australia: Results from the HOPE study	3
Disease remission of refractory vulvovaginal and gingival lichen planus with tildrakizumab	3
Bullous pemphigoid in kidney transplant rejection: A case report and literature review	3
Refractory Head and Neck atopic dermatitis pattern treated with Dupilumab: Allergic contact dermatitis caused by decyl glucoside. Should surfactants be patched?	3
Eruptive Bowen's Disease in a patient on pembrolizumab for Hodgkin's lymphoma	3
Roles of gut‐microbiota and probiotics in chronic urticaria: A systematic review and meta‐analysis	3
Cutaneous squamous cell carcinoma metastatic to the axilla and groin: Outcomes and prognostic factors	3
Trichofolliculoma – ‘troll hair’ dermoscopy	3
Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies – Adult patients	3
CM‐AVM syndrome – A prospective observational study of unrelated paediatric cases	3
Evaluation of dynamic dermoscopic features of melanoma and benign naevi by sequential digital dermoscopic imaging and total body photography in a high‐risk Australian cohort	3
Patch testing in New Zealand: Barriers to evidence‐based care	3
Erosive pustular dermatosis of the scalp‐like eruption from panitumumab	3
Risk of subsequent keratinocyte carcinomas after a first diagnosis in Tasmania, Australia	3
Is pyoderma gangrenosum associated with solid malignancies? Insights from a population‐based cohort study	3
Dermatological services; patient profiling in a rural tertiary hospital	3
Porokeratoma in the nipple: A case report	3
Successful treatment of idiopathic Harlequin Syndrome with oxybutynin and propranolol	3
Double vision due to lateral rectus injury after cosmetic botulinum toxin injections	3
Melanoma diagnosis at a specialist dermatology practice without the use of photographic surveillance	3
Knowledge and attitudes of Australian dermatologists towards sentinel lymph node biopsy for melanoma: a mixed methods study	3
Hidradenitis suppurativa and Down syndrome in a single‐centre sample: A cross‐sectional study	3
Diffuse congenital hypotrichosis simplex with associated hair shaft fragility	3
Hydroxyurea‐induced squamous cell carcinoma	3
Pseudoepitheliomatous keratotic and micaceous balanitis: A literature review	3
Inter‐ and intra‐patient heterogeneity of PD‐L1 expression in metastatic melanomas: A retrospective study	3
Prurigo pigmentosa: An institutional retrospective study of 24 patients	3
Remission of chronic spontaneous urticaria following omalizumab with gradually extended dosing intervals: Real‐life data	3
Transient hypertriglyceridaemia associated with propranolol for treatment of infantile hemangioma	3
Intravenous immunoglobulin treatment for refractory pyoderma gangrenosum	3
Miliaria crystallina induced by idarubicin and all‐trans‐retinoic acid: Two case reports	3
Neoadjuvant intralesional methotrexate in small‐sized cutaneous squamous cell carcinoma: a prospective study in 84 patients	3
Three cases of Sneddon syndrome: A comparison with lymphocytic thrombophilic arteritis	3
The value of adding platelet‐rich plasma (PRP) to noncultured epidermal cell suspension (NCECS) in surgical treatment of stable resistant vitiligo: A self‐controlled randomised d	3
Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in a solid organ transplanted recipient: A case report	3
Comparison of cyclosporine and systemic corticosteroid for treating drug reaction with eosinophilia and systemic symptoms syndrome: A retrospective 20‐year single‐centre study in South Korea	3
Grenz ray therapy in disseminated superficial actinic porokeratosis: A case series of 17 patients	3
Platelet count and plateletcrit: Potential haematological biomarkers for livedoid vasculopathy?	3
Hyperkeratotic flexural erythema/granular parakeratosis responding to doxycycline	3
Multi‐drug resistant dermatophyte infections in Western Sydney: A retrospective case series	3
A review of the cutaneous toxicities of tebentafusp—Featuring two cases involving superficial bullous reactions	3
Recurrent cutaneous necrotising eosinophilic vasculitis	3
Assessment of potential predictive factors of dupilumab response in patients with moderate‐to‐severe atopic dermatitis	3
Eruptive vellus hair cysts diagnosed using dermatological imaging technique	3
Comparison of the EUROIMMUN Dermatology Profile ELISA to the novel BIOCHIP Mosaic 7 for the diagnosis of immunobullous skin disease	3
Secondary alopecia induced by aesthetic procedures: An unrecognized potential complication	3
A baseline patch test series for New Zealand	3
Burden of proof—Critical flaws in the recommendations from the commission on human medicines Isotretinoin expert working group	3
Rivaroxaban in the treatment of TEK‐related venous malformation	3
Severe progressive scarring pembrolizumab‐induced lichen planopilaris in a patient with metastatic melanoma	3
Subcutaneous panniculitis‐like T‐cell lymphoma in a 14‐year‐old female homozygous for HAVCR2 mutation	3
Hypopigmented mycosis fungoides: A 48‐case retrospective series	3
Cutaneous T‐cell lymphoma mimicking palmoplantar pustular psoriasis: A rare variant	2
Intralesional 5‐fluorouracil as a management for cutaneous squamous cell carcinomas: A rural Australian retrospective case series	2
Bullous pemphigoid: Its incidence, mortality and clinical outcome in New Zealand	2
A case of omalizumab as a successful treatment for telangiectasia macularis eruptiva perstans	2
A cross‐sectional study of depression and quality of life in psoriasis	2
Treatment of severe, refractory pyoderma gangrenosum with infliximab, adalimumab and intravenous immunoglobulin	2
Two cases of yellow urticaria revealing acute lithiasic biliary disease	2
Expression of survivin and p53 genes in patients with alopecia areata: A case–control study	2
Two cases of acquired perforating dermatosis successfully treated with allopurinol	2
Serum levels and expression of IL‐25 in patients with psoriatic erythroderma	2
Photosensitive generalised guttate lichen sclerosus et atrophicus: A rare presentation	2
Dual biologic therapy with Omalizumab and Dupilumab for refractory atopic disease	2
Skin collision tumour and dermoscopic diagnosis of melanoma in situ and dilated pore of Winer	2
The impact of hidradenitis suppurativa on quality of life is worse than inflammatory bowel disease and myocardial infarction	2
Hair and Nails	2
	2
	2
Demographic and epidemiological drivers of global burden of psoriasis	2
First report of Mal de Meleda with pseudo‐ainhum treated with gabapentin in a 17‐year‐old Chinese girl	2
Identifying predictors of systemic immunosuppressive treatment of vulvovaginal lichen planus: A retrospective cohort study of 122 women	2
Bacillus thuringiensis: a causative agent of pitted keratolysis	2
Three cases of symmetrical drug‐related intertriginous and flexural exanthema (SDRIFE) induced by proton‐pump inhibitors	2
Mental health, insomnia and suicidal ideation during treatment with apremilast	2
	2
Acute generalised exanthematous pustulosis after initiation of palbociclib therapy for metastatic breast cancer	2
Pemphigoid and pemphigus: Comparative analysis of clinical epidemiology, course and outcome in an Asian Academic Medical Centre	2
Cross‐sectional study of pigmented lesions of the head and neck in adults aged 40 years and above	2